Presence of EMCDDA staff at Lisbon Addictions 2022

About

Lisbon Addictions 2022, the European Conference on Addictive Behaviours and Dependencies, takes place at the Lisbon Congress Centre from 23–25 November 2022, under the overarching theme of Global Addictions. The event showcases the latest scientific knowledge in this domain and explore challenges relating to illicit drugs, alcohol, tobacco, screen addiction, gambling and other addictive behaviours.

EMCDDA staff members are among the more than 1 000 speakers at the conference, and they will present the latest information and data in their area of expertise. Below you can see a full listing of EMCDDA staff presence at the conference, as well as the different side events organised by the EMCDDA.

An exhibition stand at the event will showcase the latest EMCDDA products and services. The agency's staff will be present on the stand to guide visitors and explore customer information needs.

Last update: 27 October 2022

Wednesday, 23 November

• 8.30: Plenary session, Official opening, Alexis Goosdeel
• 10.50, Structured session: Emerging changes in Europe's cannabis situation: policy preparedness and responses to a dynamic situation, Jane Mounteney, Chair
• Oral presentation: Medical use of cannabis and cannabinoids: an overview of evidence, Liesbeth Vandam
• 10.50, Oral presentation: Addressing substance use and related problems in reception settings in Europe, Klaudia Palczac
• 13.20, Structured session: Migration, substance use and interventions in Europe, Klaudia Palczac, Chair
• Oral presentation: Equitable substance use treatment for migrants, refugees and ethnic minorities: An emerging research domain, Inês Hasselberg
• 13.20, Structured session: The future for Digital Addictions Services. An update from the DigitAS-DADE Project, Marica Ferri, Chair
• Discussion: Are Digital Health Interventions for Addiction Services more likely to widen or narrow inequalities?, Marica Ferri
• 13.20, Structured session: Prevention and control of infectious diseases among people who inject drugs: key recommendations and new evidence within the updated guidance from the ECDC and the EMCDDA, Thomas Seyler
• Oral presentation: Key recommendations from the updated ECDC/EMCDDA guidance on the prevention and control of infectious diseases among people who inject drugs, Anne Bergenstrom
• Discussion: Perspectives from government and civil society member(s) of the ECDC and EMCDDA expert panelon the key areas of intervention and recommendations, Anne Bergenstrom
• 13.20, Structured session: Policies for regulating cannabis supply in Europe and the US: the need for appropriate monitoring and evaluation, Liesbeth Vandam, Chair
• Discussion: Adapting monitoring and evaluation to the different versions of 'legalisation', while exploring possible common indicators, Brendan Hughes
• 13.20, Structured session: Special at-risk populations and need for diversified interventions to prevent overdoses: insights from the US and Europe, on fentanyl, suicidal overdoses and deaths among teen-agers, Isabelle Giraudon
• Oral presentation: Fentanyl related deaths and fentanyl acute toxicity presentations at emergency Departments in Europe, 2010-2020, Peter Heudtlass
• 15.00, Oral presentation: Analysis of drugs in used syringes from sentinel European cities, 2020, Thomas Seyler
• 15.00, Structured session: INDRA: dialogues for an international didactic repository for addictions, Marica Ferri, Chair
• Oral presentation: PLATO, an e-learning platform for European learners, Marica Ferri
• 15.00, Structured session: Drug Early Warning Systems – the key to preparedness and response to new psychoactive substances, Ana Gallegos, Roumen Sedefov, Chairs
• Oral presentation: Global markets, glocal threats: Early warning, preparedness, and response to new psychoactive substances in Europe, Michael Evans-Brown
• 15.00, Structured session: Substance use and mental health disorders in Europe: prevalence, models of care, and implementation in a challenging COVID19 context, Linda Montanari, Jane Mouteney, Chairs
• 15.00, Structured session: How prepared are monitoring systems to respond to rapidly changing drug markets in regions bordering the European Union?, Ilze Jekabsone, Frédéric Denecker, Chairs
• Oral presentation: Key developments in drug markets of Western Balkans, Katerina Skarupova, Robert Patrancus
• 15.00, Discussion: Synergies and challenges each region faces in relation to the model/s within which DCRs operate, Jane Mounteney
• 15.00, Short communication session, Surveillance, João Matias, Chair
• 16.50, Oral presentation: Policy and legislation, Brendan Hughes
• 16.50, Workshop: Economic recessions, COVID-19, socio-determinants of drug use and its harms: deaths of despair?, Liesbeth Vandam, Chair
• Oral presentation: The Impact of Economic Recessions on the Use of Illicit Drugs: a Systematic Review of Literature and a Meta-Analysis, Cláudia Costa-Storti

Thursday, 24 November

• 13.20, Structured session: The globalised illicit drug market, Roumen Sedefov, Chair
• 13.20, Structured session: Environmental prevention: why do we need it now and how to advance it?, Gregor Burkhart
• Discussion: What is environmental prevention and its state of development, Gregor Burkhart
• 13.20, Oral presentation: How many people injected illicit drugs in the European Union in 2019?, Filippo Pericoli
• 13.20, Oral presentation: Estimates of people who injected drugs within the last 12 months in Belgium, Luk Van Baelen
• 15.00, Oral presentation: Deaths among acute drug toxicity presentations to the Euro-DEN Plus Network 2014-2020, Isabelle Giraudon
• 16:50, Structured session: Opportunities and challenges for countries in transition to overcome barriers to evidence-based policies and interventions, Luk Van Baen
• Oral presentation: Capacity building for practitioners on evidence-based drug treatment interventions aligned with EU quality standards and tailored to national needs, Anna Tarján
• Discussion: European Prevention Curriculum, Gregor Burkhart
• 16.50, Structured session: Prison and drugs: exploring social determinants and pathways to drug problem and incarceration, Linda Montanari
• Discussion: Common pathways to problematic drug use and incarceration and lessons learnt for policy and practice, Liesbeth Vandam

Friday, 25 November

• 10.50, Workshop: A Digital Future? Engaging online communities of people who use drugs to influence policy and practice, Alexander Soderholm, Chair
• 10.50, Oral presentation session: Harm reduction or prevention? Gregor Burkhart
• 13.20, Structured session: Barriers in the implementation of harm reduction interventions in European prisons. From evidence to practice, Linda Montanari, Liesbeth Vandam, Chairs
• Oral presentation: Provision of harm reduction interventions in European prisons: short overview of available services, Linda Montanari
• 15.00, Plenary session, The Richard Hartnoll memorial lecture, Paul Griffiths, Chair
• Introduction, Richard Hartnoll – a seminal contributor to the development of the EMCDDA and drug epidemiology, Paul Griffiths
• 15.30, Plenary session, Closing keynote, Providing care in a time of war — perspectives from Ukraine, Paul Griffiths

e-posters and e-short communications

e-short communication: Monitoring opioid agonist maintenance treatment outcomes for people who use opioids and public health, Lucas Wiessing

e-poster: Hair drug testing as an epidemiological tool to investigate patterns of drug use: a multi-country study, João Matias

Side events

• IPA7 and EU4MD closing event, 21 November
• EUPC training event, 21-22 November
• Symposium on gender and drugs, 22 November

For more information on the various events organised alongside the Lisbon Addictions conference visit the Side events section of the Lisbon Addictions website.

 Lisbon Addictions 2022